Lindsey Rolfe

All filings by Lindsey Rolfe on record concern Clovis Oncology, Inc. Over a trading history stretching from 4 February 2020 to 1 November 2022, the count stands at 44 filings.

On the market, this insider has only sold: 14 sales, €126k in total. Outside the open market, there are 2 share grants and 28 option exercises.

On 3 November 2022 came the latest disclosure, an option exercise in Clovis Oncology, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.